ArcBest price target lowered to $145 from $160 at Morgan Stanley

Morgan Stanley analyst Ravi Shanker lowered the firm’s price target on ArcBest (ARCB) to $145 from $160 and keeps an Overweight rating on the shares. Q4 featured “a healthy beat,” but Q1 trends pointed well below the firm’s and consensus estimates on both volumes and margin, notes the analyst. If peers send a similar message next week, the less-than-truckload bull case is “likely to come under more pressure despite the upcycle,” the analyst added.